Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-673-7 | CAS number: 94944-95-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 June 2017 to 12 October 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Version / remarks:
- The Japanese Ministry of Health, Labour and Welfare (MHLW), Ministry of Economy Trade and Industry (METI), and Ministry of the Environmental (MOE) Guidelines of 31 March 2011
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Fatty acids, C18-36, esters with ethylene glycol
- EC Number:
- 305-673-7
- EC Name:
- Fatty acids, C18-36, esters with ethylene glycol
- Cas Number:
- 94944-95-3
- Molecular formula:
- C40H78O4/C70H138O4
- IUPAC Name:
- Fatty acids, C18-36, esters with ethylene glycol
- Test material form:
- solid
Constituent 1
Method
- Target gene:
- NA
Species / strain
- Species / strain / cell type:
- lymphocytes:
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: human peripheral lymphocytes
- Suitability of cells: standard cells (checked for exposure to high levels of radiation or hazardous chemicals and not knowingly recently suffered from a viral infection)
- Cell cycle length, doubling time or proliferation index: AGT 16 hours
- Sex, age and number of blood donors if applicable: Preliminary Toxicity Test: male, aged 31 years; Main Experiment: female, aged 30 years
- Whether whole blood or separated lymphocytes were used if applicable: fresh heparinized whole blood
- Methods for maintenance in cell culture: grown in Eagle's minimal essential medium with HEPES buffer (MEM), supplemented “in-house” with L-glutamine, penicillin/streptomycin, amphotericin B and 10 % foetal bovine serum (FBS), at approximately 37 ºC with 5 % CO2 in humidified air
- Modal number of chromosomes: 44-48
- Normal (negative control) cell cycle time: 16 hours
MEDIA USED
- Type and identity of media including CO2 concentration: MEM at approximately 37 ºC with 5 % CO2
- Properly maintained: yes
- Cytokinesis block (if used):
- demecolcine (Colcemid 0.1 µg/mL) 2.5 hours before the required harvest time.
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from rat livers induced with phenobarbital/beta-naphthoflavone
- Test concentrations with justification for top dose:
- Exposure Group Final concentration of
4(20)-hour without S9 0*, 1.25, 2.5, 5, 8*, 10*, 20*, 40, MMC 0.4*
4(20)-hour with S9 (2%) 0*, 5, 8, 10, 15*, 20*, 40*, 80, CP 1*
24-hour without S9 0*, 1.25, 2.5, 5, 8*, 10*, 20*, 40, MMC 0.1*
* Dose levels selected for metaphase analysis - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Tetrahydrofuran (THF)(0.25% in 25 µl aliquots; maximum achieved dosing concentration 625 µg/mL)
- Justification for choice of solvent/vehicle: insoluble in dimethyl sulphoxide at 125, 250 and 500 mg/mL and acetone at 250 and 500 mg/mL. However, the substance was soluble in THF at 500 mg/mL
Controls
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- DURATION
- pre-incubation: 48 hours at approximately 37 ºC, 5% CO2 in humidified air
- Exposure duration: 4 hour with and without metabolic activation, 24 hours without metaboliv activation at approximately 37 ºC, 5% CO2 in humidified air
- Expression time (cells in growth medium): 4 hour tests: 20 hours at approximately 37 ºC, 5% CO2 in humidified air
SPINDLE INHIBITOR: Mitosis was arrested by addition of demecolcine (Colcemid 0.1 µg/mL) 2.5 hours before the required harvest time. After incubation with demecolcine, the cells were centrifuged, the culture medium was drawn off and discarded, and the cells re-suspended in 0.075M hypotonic KCl. After approximately fourteen minutes (including centrifugation), most of the hypotonic solution was drawn off and discarded. The cells were re-suspended and then fixed by dropping the KCl cell suspension into fresh methanol/glacial acetic acid (3:1 v/v). The fixative was changed at least three times and the cells stored at approximately 4 ºC to ensure complete fixation prior to slide preparation.
STAIN: Giemsa
NUMBER OF REPLICATIONS: 2/concentration
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: The lymphocytes were re-suspended in several mL of fresh fixative before centrifugation and re-suspension in a small amount of fixative. Several drops of this suspension were dropped onto clean, wet microscope slides and left to air dry. Each slide was permanently labeled with the appropriate identification data.
When the slides were dry they were stained in 5% Giemsa for 5 minutes, rinsed, dried and a cover slip applied using mounting medium.
NUMBER OF CELLS EVALUATED: 2000/concentration for mitotic index
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE : 300 consecutive well-spread metaphases from each concentration were counted (150 per duplicate)
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: cells with 69 chromosomes or more were scored as polyploid cells
- Determination of endoreplication: recorded separately and included in the polyplod cell total - Rationale for test conditions:
- standard according to the guidance
- Evaluation criteria:
- •The frequency of cells with structural chromosome aberrations (excluding gaps) in the vehicle control cultures was within the laboratory historical control data range
•All the positive control chemicals induced a positive response (p≤0.01) and demonstrated the validity of the experiment and the integrity of the S9-mix
•The study was performed using all three exposure conditions using a top concentration which meets the requirements of the current testing guideline
•The required number of cells and concentrations were analyzed - Statistics:
- Fisher's Exact test (p<0.05)
Results and discussion
Test results
- Key result
- Species / strain:
- lymphocytes: human lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: none
- Effects of osmolality: none
- Evaporation from medium: none
- Water solubility: see vehicle selection
- Precipitation: yes at 20 ug/mL in tests without metabolic activation and at 40 ug/mL in test with metabolic activation
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: available (all findings were within historical control values)
- Negative (solvent/vehicle) historical control data: available (all findings were within historical control values)
ADDITIONAL INFORMATION ON CYTOTOXICITY: no cytotoxicity observed
Any other information on results incl. tables
details see attached document
Applicant's summary and conclusion
- Conclusions:
- The substance is considered not clastogenic under the conditions of the test
- Executive summary:
Duplicate cultures of human lymphocytes, treated with the test item, were evaluated for chromosome aberrations at up to four dose levels, together with vehicle and positive controls. In this study, three exposure conditions were investigated;4 hours exposure in the presence of an induced rat liver homogenate metabolizing system (S9), at a 2% final concentration with cell harvest after a 20-hour expression period, 4 hours exposure in the absence of metabolic activation (S9) with a 20-hour expression period and a 24-hour exposure in the absence of metabolic activation.
The dose levels used in the Main Experiment were selected using data from the preliminary toxicity test where the results indicated that the maximum concentration should be limited by precipitate. The dose levels selected for the Main Test were as follows:
Group
Final concentration of substance evaluated
4(20)-hour without S9
0, 8, 10, 20
4(20)-hour with S9 (2%)
0. 15, 20, 40
24-hour without S9
0, 8, 10, 20
All vehicle (Tetrahydrofuran) controls had frequencies of cells with aberrations within the range expected for normal human lymphocytes.
All the positive control items induced statistically significant increases in the frequency of cells with aberrations. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The test item did not demonstrate any marked toxicity and did not induce any statistically significant increases in the frequency of cells with aberrations, using a dose range that included a dose level that was the lowest precipitating dose level.
The test item,was considered to be non-clastogenic to human lymphocytes in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.